BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2737629
Number of visits today
516
Number of downloads
2008993
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Abulaiti A, Maimaiti A, Yiming N, Fu Q, Li S, Li Y, Wang Y, Zhou Q. Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in Lower-grade glioma.. [DOI: 10.21203/rs.3.rs-2541405/v1] [Reference Citation Analysis]
2 Mall R, Bynigeri RR, Karki R, Malireddi RKS, Sharma BR, Kanneganti TD. Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology. NAR Cancer 2022;4:zcac033. [PMID: 36329783 DOI: 10.1093/narcan/zcac033] [Reference Citation Analysis]
3 Qiang S, Fu F, Wang J, Dong C. Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making. Front Genet 2022;13:1007108. [DOI: 10.3389/fgene.2022.1007108] [Reference Citation Analysis]
4 Wu Z, Zhang F, Wang Y, Lu Z, Lin C. Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment. Cancers 2022;14:4364. [DOI: 10.3390/cancers14184364] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345